A statement from Frank A. Segall, Chair of Blank Rome’s Cannabis Industry Group:
The Trump Administration’s move on the rescheduling of cannabis is long overdue and monumental. It recognizes the importance of further legitimizing the health and wellness benefits of this miracle plant, allowing research and clinical trials to advance, and expanding access for those who may benefit from its medicinal properties.
However, meaningful and equitable access for all Americans, and fair treatment of the industry comparable to that extended to all other businesses, will only be achieved with full rescheduling of cannabis.
To read the full post, please visit our Cannabis Industry Insights blog.